Jilin Jian Yisheng Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jilin Jian Yisheng Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥472.8M, which brings its debt-to-equity ratio to 20.1%. Its total assets and total liabilities are CN¥3.1B and CN¥701.3M respectively. Jilin Jian Yisheng Pharmaceutical's EBIT is CN¥72.9M making its interest coverage ratio -15.8. It has cash and short-term investments of CN¥617.9M.
Key information
20.1%
Debt to equity ratio
CN¥472.76m
Debt
Interest coverage ratio | -15.8x |
Cash | CN¥617.89m |
Equity | CN¥2.35b |
Total liabilities | CN¥701.33m |
Total assets | CN¥3.06b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002566's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥577.7M).
Long Term Liabilities: 002566's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥123.6M).
Debt to Equity History and Analysis
Debt Level: 002566 has more cash than its total debt.
Reducing Debt: 002566's debt to equity ratio has reduced from 22.2% to 20.1% over the past 5 years.
Debt Coverage: 002566's debt is well covered by operating cash flow (36.3%).
Interest Coverage: 002566 earns more interest than it pays, so coverage of interest payments is not a concern.